Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course
Alexandra Domnica Hoeggerl(Paracelsus Medical University), Sandra Laner‐Plamberger(Paracelsus Medical University), Lisa Weidner(Harvard University), Jürgen Osterbrink(Paracelsus Medizinische Privatuniversität), Eva Rohde(Medical University of Graz), Christof Jungbauer(Paracelsus Medical University), Nadja Lindlbauer(Paracelsus Medical University), Verena Nunhofer(Paracelsus Medical University), Natalie Badstuber(University of Salzburg), Maria Flamm(Paracelsus Medical University), Nina Held(Paracelsus Medical University), Georg Zimmermann(University of Salzburg), Wanda Lauth(Fachhochschule Salzburg), Tuulia M. Ortner(University of Salzburg), Heidrun Neureiter(Paracelsus Medical University), Christoph Grabmer(Paracelsus Medical University)
Cited by 19
Related Papers
Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
|Stem Cells Translational Medicine|2017|359
Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas
|International Journal of Mass Spectrometry|2007|276
Humanized large-scale expanded endothelial colony–forming cells function in vitro and in vivo
|Blood|2009|205
Rapid Large-Scale Expansion of Functional Mesenchymal Stem Cells from Unmanipulated Bone Marrow Without Animal Serum
|Tissue Engineering Part C Methods|2008|179
Prognostic relevance of serum lactate kinetics in critically ill patients
|Intensive Care Medicine|2018|166